Consider buying TriplePoint Venture Growth (TPVG), where the CEO and CIO just made their largest-ever monthly stock purchase, totaling nearly $5 million. Infinity Natural Resources (INFI) also presents a strong buy signal, with the CEO making a first-ever purchase and a director making their largest buy after a 30% stock decline. Conversely, widespread insider selling at ANI Pharmaceuticals (ANIP), totaling over $35 million from 13 executives, signals a potential top after its recent 60% rally. Caution is also warranted for Skye Bioscience (SKYE), as a major owner with a history of successful timing sold a large position after the stock's recent surge. These insider actions suggest potential near-term upside in TPVG and INFI, while indicating significant risk in ANIP and SKYE.

Infinity Natural Resources (INFI)

• Two insiders, including the CEO and a director, collectively purchased over $750,000 worth of stock.
• The stock has declined 30% in the last 6 months, indicating these insiders are "buying the dip."
• CEO Purchase: This was the CEO's first-ever purchase of company stock, which is often considered a strong signal of confidence.
• Director Purchase:
  • This was the director's largest purchase ever out of six total purchases.
  • This single purchase increased the director's holdings by over 300%.
  • This specific director has a strong track record, averaging nearly 20% returns within one month on their previous purchases.

Takeaways

• The combination of a CEO's first-ever buy and a historically successful director making their largest-ever buy suggests a strong bullish signal.
• Insiders may believe the stock is significantly undervalued after its recent 30% drop.
• The director's past performance on trades could suggest potential for a near-term rebound, although past performance is not indicative of future results.

Coty Inc. (COTY)

• A group of top executives, including the CEO, the Chief Financial Officer (CFO), and the Chief People Officer, collectively bought over $1.1 million of stock.
• These are the first insider purchases at the company in over a year and a half, breaking a long period of no insider buying.
• The stock is down significantly, having fallen over 50% in the last year and 20% in the last 6 months, suggesting executives are buying into weakness.

Takeaways

• Coordinated buying from the highest level of management (CEO, CFO) is a powerful vote of confidence in the company's future.
• The fact that these are the first insider buys in over 18 months makes the signal particularly noteworthy. Insiders may feel the stock has bottomed out and is poised for a recovery.

TriplePoint Venture Growth (TPVG)

• There is continued and aggressive buying from the Chief Executive Officer (CEO) and the Chief Investment Officer (CIO).
• In August alone, they purchased a combined total of almost $5 million worth of stock.
• This amount is exceptionally high for them, representing over 20 times more than any other month in which they have purchased the stock.

Takeaways

• The significant acceleration in buying by the CEO and CIO suggests a very high level of conviction.
• This isn't just a small, symbolic purchase; it's a substantial financial commitment that indicates they see a major opportunity at the current valuation. This is a strong bullish indicator.

Skye Bioscience, Inc. (SKYE)

• A 10% owner of the company sold $800,000 worth of stock in an unscheduled sale.
• The stock has run up significantly, gaining almost 60% in the last three months, meaning the insider is "selling the rip."
• Historical Context: The last time this specific insider sold, the stock fell over 40% in the following three months.

Takeaways

• This is a potentially strong bearish signal, given the insider's track record.
• The sale comes after a major price increase, suggesting the insider may believe the stock is now overvalued or has peaked for the near term.
• Investors should be cautious, as the previous sale by this insider preceded a significant drop in the stock price.

ANI Pharmaceuticals (ANIP)

• There has been massive and widespread insider selling after the stock's recent 60% run-up in the last three months.
• In August alone, 13 different insiders sold stock 15 times, totaling over $35 million in sales.
• The volume of selling is unprecedented for the company, being over 10 times more than any other period of selling in the company's history.

Takeaways

• Widespread selling across a large number of insiders is a significant red flag. It suggests a broad consensus among management that the stock's valuation is too high after its rapid ascent.
• This is not just one or two insiders taking profits; it's a large-scale exit that could signal a top for the stock.

Home Depot (HD)

• Six different insiders collectively sold nearly $20 million of stock.
• All of these sales were unscheduled, which can be more significant than pre-planned sales.
• This type of coordinated, unscheduled selling by multiple insiders is described as a very rare occurrence for Home Depot.
• Historical Context: The podcast notes that the only two other times this happened were in February 2024 and November 2024, after which the stock performed poorly for the next 6 months. (Note: The "November 2024" date is in the future and likely a transcript error, possibly referring to a past year like 2021 or 2022. However, the negative historical correlation is the key point.)

Takeaways

• This rare and coordinated selling by a group of insiders is a bearish warning sign.
• The historical pattern mentioned suggests that such events have preceded periods of stock underperformance.
• While insiders can sell for many reasons, the rarity and coordinated nature of this event at a blue-chip company like Home Depot warrant caution.